Treatment with chemical inhibitors of ALDH activity sensitizes normal human HSCs and HPCs to the alkylating agent mafosfamide [103], and murine HPCs to 4-HC [104], a clinically used drug for ex vivo purging of residual cancer cells and treatment with autologous bone marrow transplantation [105]. Here, LDHA is linked to cancer.